Beta-defensin 1
experimentalAlso known as: Defensin, beta 1, DEFB1, P60022
Beta-defensin 1 (DEFB1) is an antimicrobial peptide with a primary mechanism involving direct bactericidal activity against Gram-positive and Gram-negative bacteria through membrane disruption. It also functions as a ligand for C-C chemokine receptor 6 (CCR6), triggering intracellular calcium mobilization and downstream signaling. This CCR6-dependent pathway has been shown to positively regulate sperm motility and enhance bactericidal activity, suggesting a dual role in host defense and reproductive physiology. Key research findings indicate that DEFB1 expression is constitutive in epithelial tissues, including the respiratory and urogenital tracts, contributing to mucosal immunity. Studies have linked polymorphisms in the DEFB1 gene to altered susceptibility to infections, such as chronic obstructive pulmonary disease and cystic fibrosis exacerbations. Additionally, its role in sperm function highlights potential implications for male fertility, with evidence that DEFB1-mediated CCR6 signaling supports sperm capacitation and motility. Clinically, DEFB1 is under investigation as a biomarker for infection risk and as a therapeutic target for enhancing innate immunity. Its antimicrobial properties and chemotactic activity via CCR6 position it as a candidate for developing novel anti-infective agents, particularly in contexts of antibiotic resistance. However, its experimental status limits current clinical applications. For research purposes only — not medical advice.
Key data
MRTSYLLLFTLCLLLSEMASGGNFLTGLGHRSDHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCKMechanism of action
Has bactericidal activity. May act as a ligand for C-C chemokine receptor CCR6. Positively regulates the sperm motility and bactericidal activity in a CCR6-dependent manner. Binds to CCR6 and triggers Ca2+ mobilization in the sperm which is important for its motility (PubMed:25122636)
Research & studies
DEFB1 expression was higher in degenerated human and rat IVD tissues compared to non-degenerated samples.; DEFB1 knockdown increased cell viability and decreased senescence, apoptosis, and G1-phase arrest in NP and AF cells under IL-1 stimulation.; DEFB1 knockdown reduced ERK1/2 phosphorylation in vivo and in vitro, and an ERK antagonist reversed the effects of DEFB1 overexpression.; Targeting DEFB1 may offer a therapeutic strategy for IDD by modulating ERK signaling.
Human β-defensin-1 reduced proliferation of colon cancer cells.; Autophagy activation was associated with inhibition of mammalian target of rapamycin.; Increased Beclin1 and LC3II/I proteins indicated autophagy activation.; Upregulation of long non-coding RNA TCONS_00014506 mediated the autophagy activation.
Frequently asked questions
What is Beta-defensin 1?
Beta-defensin 1 (DEFB1) is an antimicrobial peptide with a primary mechanism involving direct bactericidal activity against Gram-positive and Gram-negative bacteria through membrane disruption. It also functions as a ligand for C-C chemokine receptor 6 (CCR6), triggering intracellular calcium mobilization and downstrea
How does Beta-defensin 1 work?
Has bactericidal activity. May act as a ligand for C-C chemokine receptor CCR6. Positively regulates the sperm motility and bactericidal activity in a CCR6-dependent manner. Binds to CCR6 and triggers Ca2+ mobilization in the sperm which is important for its motility (PubMed:25122636)
What is the research status of Beta-defensin 1?
Beta-defensin 1 is currently classified as experimental, with 651 research references on record. This is for research purposes only and is not medical advice.
What is the molecular weight of Beta-defensin 1?
Beta-defensin 1 has a molecular weight of approximately 7420 g/mol.
Related peptides
Liver-produced hormone that constitutes the main circulating regulator of iron absorption and distribution across tissues.
Human cathelicidin antimicrobial peptide with broad-spectrum antibacterial, immunomodulatory, and wound-healing activity.
Antimicrobial protein that kills intracellular pathogens.
28-aa thymic peptide that enhances T-cell maturation and TLR signaling; approved in many countries for hepatitis and as an immune adjuvant.
Zinc-dependent thymic nonapeptide that regulates T-cell differentiation and has analgesic and anti-inflammatory effects.
Lysozymes have primarily a bacteriolytic function; those in tissues and body fluids are associated with the monocyte-macrophage system and enhance the activity of immunoagents
Build on Beta-defensin 1 data programmatically
Structured peptide data, semantic search, and AI summaries via one API.
Get a free API key